(DDS) Dillard's - Ratings and Ratios
Apparel, Accessories, Cosmetics, Furnishings
DDS EPS (Earnings per Share)
DDS Revenue
Description: DDS Dillard's
Dillards, Inc. is a retail department store chain operating primarily in the southeastern, southwestern, and midwestern United States, offering a wide range of products including fashion apparel, accessories, cosmetics, and home furnishings through various channels, including its e-commerce platform and clearance centers.
From a business perspective, Dillards has a strong presence in its operating regions, with a diverse product portfolio that caters to different demographics. The companys ability to manage its supply chain and inventory is crucial, as reflected in its gross margin ratio, which is a key performance indicator (KPI) for retailers. A high gross margin ratio indicates effective inventory management and pricing strategies.
In terms of financial health, Dillards has demonstrated a strong return on equity (RoE) of 28.42%, indicating efficient use of shareholder capital. To further evaluate the companys financial performance, other relevant KPIs include the debt-to-equity ratio, current ratio, and sales per square foot, which can provide insights into its capital structure, liquidity, and operational efficiency.
To assess Dillards competitive position and growth prospects, its essential to analyze industry trends, consumer behavior, and the companys omnichannel retail strategy. The rise of e-commerce has transformed the retail landscape, and Dillards has responded by investing in its online platform. The companys ability to balance its brick-and-mortar presence with e-commerce growth will be critical to its long-term success.
From a valuation perspective, Dillards price-to-earnings (P/E) ratio of 12.10 and forward P/E ratio of 19.57 suggest that the market expects earnings growth in the future. To determine whether the stock is undervalued or overvalued, its necessary to compare these multiples with industry averages and consider other fundamental factors, such as revenue growth, profit margins, and return on assets (RoA).
DDS Stock Overview
| Market Cap in USD | 9,149m |
| Sub-Industry | Broadline Retail |
| IPO / Inception | 1989-06-30 |
DDS Stock Ratings
| Growth Rating | 80.8% |
| Fundamental | 75.7% |
| Dividend Rating | 64.7% |
| Return 12m vs S&P 500 | 49.0% |
| Analyst Rating | 2.0 of 5 |
DDS Dividends
| Dividend Yield 12m | 0.31% |
| Yield on Cost 5y | 5.54% |
| Annual Growth 5y | 112.50% |
| Payout Consistency | 98.0% |
| Payout Ratio | 2.9% |
DDS Growth Ratios
| Growth Correlation 3m | 95.3% |
| Growth Correlation 12m | 48.1% |
| Growth Correlation 5y | 94% |
| CAGR 5y | 33.47% |
| CAGR/Max DD 3y | 0.80 |
| CAGR/Mean DD 3y | 2.37 |
| Sharpe Ratio 12m | 0.94 |
| Alpha | 0.05 |
| Beta | 0.648 |
| Volatility | 42.03% |
| Current Volume | 102.6k |
| Average Volume 20d | 114.6k |
| Stop Loss | 571.3 (-3.6%) |
| Signal | 1.73 |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (575.7m TTM) > 0 and > 6% of Revenue (6% = 395.1m TTM) |
| FCFTA 0.21 (>2.0%) and ΔFCFTA 6.40pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.50% (prev 24.79%; Δ -0.29pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.23 (>3.0%) and CFO 857.6m > Net Income 575.7m (YES >=105%, WARN >=100%) |
| Net Debt (-660.9m) to EBITDA (921.9m) ratio: -0.72 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.7m) change vs 12m ago -3.28% (target <= -2.0% for YES) |
| Gross Margin 39.37% (prev 41.20%; Δ -1.83pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 179.3% (prev 184.3%; Δ -5.05pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 244.8 (EBITDA TTM 921.9m / Interest Expense TTM 3.05m) >= 6 (WARN >= 3) |
Altman Z'' 15.54
| (A) 0.44 = (Total Current Assets 2.57b - Total Current Liabilities 958.7m) / Total Assets 3.68b |
| (B) 1.75 = Retained Earnings (Balance) 6.46b / Total Assets 3.68b |
| warn (B) unusual magnitude: 1.75 — check mapping/units |
| (C) 0.20 = EBIT TTM 746.3m / Avg Total Assets 3.67b |
| (D) 5.33 = Book Value of Equity 6.41b / Total Liabilities 1.20b |
| Total Rating: 15.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.65
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 9.10% = 4.55 |
| 3. FCF Margin 11.70% = 2.93 |
| 4. Debt/Equity 0.21 = 2.48 |
| 5. Debt/Ebitda 0.58 = 2.25 |
| 6. ROIC - WACC 17.41% = 12.50 |
| 7. RoE 28.43% = 2.37 |
| 8. Rev. Trend -20.32% = -1.52 |
| 9. EPS Trend -47.90% = -2.39 |
What is the price of DDS shares?
Over the past week, the price has changed by +1.45%, over one month by +13.81%, over three months by +41.79% and over the past year by +77.12%.
Is Dillard's a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DDS is around 699.82 USD . This means that DDS is currently undervalued and has a potential upside of +18.06% (Margin of Safety).
Is DDS a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the DDS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 389.3 | -34.3% |
| Analysts Target Price | 389.3 | -34.3% |
| ValueRay Target Price | 775.5 | 30.8% |
Last update: 2025-09-13 05:02
DDS Fundamental Data Overview
CCE Cash And Equivalents = 1.21b USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.1823
P/E Forward = 25.2525
P/S = 1.3891
P/B = 4.7671
P/EG = -1.28
Beta = 1.034
Revenue TTM = 6.59b USD
EBIT TTM = 746.3m USD
EBITDA TTM = 921.9m USD
Long Term Debt = 425.6m USD (from longTermDebt, last quarter)
Short Term Debt = 106.5m USD (from shortTermDebt, last quarter)
Debt = 532.1m USD (Calculated: Short Term 106.5m + Long Term 425.6m)
Net Debt = -660.9m USD (from netDebt column, last quarter)
Enterprise Value = 8.47b USD (9.15b + Debt 532.1m - CCE 1.21b)
Interest Coverage Ratio = 244.8 (Ebit TTM 746.3m / Interest Expense TTM 3.05m)
FCF Yield = 9.10% (FCF TTM 770.6m / Enterprise Value 8.47b)
FCF Margin = 11.70% (FCF TTM 770.6m / Revenue TTM 6.59b)
Net Margin = 8.74% (Net Income TTM 575.7m / Revenue TTM 6.59b)
Gross Margin = 39.37% ((Revenue TTM 6.59b - Cost of Revenue TTM 3.99b) / Revenue TTM)
Tobins Q-Ratio = 1.32 (Enterprise Value 8.47b / Book Value Of Equity 6.41b)
Interest Expense / Debt = -0.43% (Interest Expense -2.30m / Debt 532.1m)
Taxrate = 18.67% (136.2m / 729.7m)
NOPAT = 607.0m (EBIT 746.3m * (1 - 18.67%))
Current Ratio = 2.68 (Total Current Assets 2.57b / Total Current Liabilities 958.7m)
Debt / Equity = 0.21 (Debt 532.1m / last Quarter total Stockholder Equity 2.48b)
Debt / EBITDA = 0.58 (Net Debt -660.9m / EBITDA 921.9m)
Debt / FCF = 0.69 (Debt 532.1m / FCF TTM 770.6m)
Total Stockholder Equity = 2.02b (last 4 quarters mean)
RoA = 15.62% (Net Income 575.7m, Total Assets 3.68b )
RoE = 28.43% (Net Income TTM 575.7m / Total Stockholder Equity 2.02b)
RoCE = 30.46% (Ebit 746.3m / (Equity 2.02b + L.T.Debt 425.6m))
RoIC = 25.23% (NOPAT 607.0m / Invested Capital 2.41b)
WACC = 7.82% (E(9.15b)/V(9.68b) * Re(8.30%)) + (D(532.1m)/V(9.68b) * Rd(-0.43%) * (1-Tc(0.19)))
Shares Correlation 3-Years: -90.08 | Cagr: -0.77%
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 75.84% ; FCFE base≈674.9m ; Y1≈613.3m ; Y5≈537.3m
Fair Price DCF = 794.8 (DCF Value 9.24b / Shares Outstanding 11.6m; 5y FCF grow -11.38% → 3.0% )
EPS Correlation: -47.90 | EPS CAGR: -28.06% | SUE: 0.70 | # QB: False
Revenue Correlation: -20.32 | Revenue CAGR: -0.86%
Additional Sources for DDS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle